Magda Rybicka

419 total citations
29 papers, 296 citations indexed

About

Magda Rybicka is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Magda Rybicka has authored 29 papers receiving a total of 296 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 10 papers in Hepatology and 6 papers in Infectious Diseases. Recurrent topics in Magda Rybicka's work include Liver Disease Diagnosis and Treatment (11 papers), Hepatitis B Virus Studies (11 papers) and Hepatitis C virus research (10 papers). Magda Rybicka is often cited by papers focused on Liver Disease Diagnosis and Treatment (11 papers), Hepatitis B Virus Studies (11 papers) and Hepatitis C virus research (10 papers). Magda Rybicka collaborates with scholars based in Poland, France and Germany. Magda Rybicka's co-authors include Krzysztof Piotr Bielawski, Joanna Nakonieczna, Anna Gwizdek‐Wiśniewska, Piotr Stalke, Mariusz Grinholc, Anna Woziwodzka, Alicja Sznarkowska, Tomasz Smiatacz, Magdalena Pazda and Jolanta Kumirska and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Journal of Clinical Microbiology.

In The Last Decade

Magda Rybicka

28 papers receiving 290 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Magda Rybicka Poland 10 88 76 71 58 56 29 296
Nahed Mohamed Egypt 11 37 0.4× 25 0.3× 97 1.4× 39 0.7× 12 0.2× 26 387
Aydın Deveci Türkiye 9 76 0.9× 16 0.2× 37 0.5× 20 0.3× 13 0.2× 32 218
Balram Ji Omar India 10 67 0.8× 14 0.2× 64 0.9× 17 0.3× 24 0.4× 41 320
Julio César García Casallas Colombia 10 47 0.5× 24 0.3× 82 1.2× 11 0.2× 5 0.1× 43 266
Ahmad Jalilvand Iran 9 52 0.6× 54 0.7× 78 1.1× 15 0.3× 8 0.1× 29 248
Dianjun Wei China 10 42 0.5× 39 0.5× 146 2.1× 22 0.4× 3 0.1× 17 343
Yao Yang China 12 37 0.4× 24 0.3× 161 2.3× 29 0.5× 25 0.4× 27 446
Siyuan Ma China 9 54 0.6× 59 0.8× 66 0.9× 34 0.6× 3 0.1× 35 296
Sébastien Perrot France 10 58 0.7× 16 0.2× 62 0.9× 10 0.2× 6 0.1× 24 328
Soumya Chatterjee India 15 89 1.0× 22 0.3× 78 1.1× 57 1.0× 13 0.2× 29 436

Countries citing papers authored by Magda Rybicka

Since Specialization
Citations

This map shows the geographic impact of Magda Rybicka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magda Rybicka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magda Rybicka more than expected).

Fields of papers citing papers by Magda Rybicka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Magda Rybicka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magda Rybicka. The network helps show where Magda Rybicka may publish in the future.

Co-authorship network of co-authors of Magda Rybicka

This figure shows the co-authorship network connecting the top 25 collaborators of Magda Rybicka. A scholar is included among the top collaborators of Magda Rybicka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Magda Rybicka. Magda Rybicka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rybicka, Magda, et al.. (2025). Growth-Inhibitory Effect of Chicken Egg Yolk Polyclonal Antibodies (IgY) on Zoonotic Pathogens Campylobacter jejuni, Salmonella spp. and Escherichia coli, In Vitro. International Journal of Molecular Sciences. 26(3). 1040–1040. 1 indexed citations
2.
Gliwiński, Mateusz, Magda Rybicka, Beata Lorenc, et al.. (2024). Residual HCV-RNA and Elevated Platelet-to-Lymphocyte Ratio Predict Poor Long-Term Outcomes in Patients with Chronic Hepatitis C After Treatment. Infectious Diseases and Therapy. 14(1). 305–315. 1 indexed citations
3.
Kaźmierczak, Maria, et al.. (2024). Genetic variations as predictors of dispositional and dyadic empathy—a couple study. Scientific Reports. 14(1). 27411–27411. 1 indexed citations
4.
Rybicka, Magda, et al.. (2023). Polymorphisms Related to Iron Homeostasis Associate with Liver Disease in Chronic Hepatitis C. Viruses. 15(8). 1710–1710. 1 indexed citations
5.
Kukuła‐Koch, Wirginia, et al.. (2023). Neuroprotective Properties of Oleanolic Acid—Computational-Driven Molecular Research Combined with In Vitro and In Vivo Experiments. Pharmaceuticals. 16(9). 1234–1234. 4 indexed citations
6.
Rybicka, Magda, Éloi R. Verrier, Thomas F. Baumert, & Krzysztof Piotr Bielawski. (2023). Polymorphisms within DIO2 and GADD45A genes increase the risk of liver disease progression in chronic hepatitis b carriers. Scientific Reports. 13(1). 6124–6124.
7.
Rybicka, Magda, Paulina Czaplewska, Jolanta Rzymowska, et al.. (2022). Novel Venetin-1 nanoparticle from earthworm coelomic fluid as a promising agent for the treatment of non-small cell lung cancer. Scientific Reports. 12(1). 18497–18497. 10 indexed citations
8.
Kaźmierczak, Maria, Paulina Pawlicka, Bogumiła Kiełbratowska, et al.. (2021). Empathy and Hormonal Changes as Predictors of Sensitive Responsiveness towards Infant Crying: A Study Protocol. International Journal of Environmental Research and Public Health. 18(9). 4815–4815. 5 indexed citations
10.
Rybicka, Magda, Alicja Sznarkowska, Piotr Stalke, et al.. (2020). Genetic variation in IL-10 influences the progression of hepatitis B infection. International Journal of Infectious Diseases. 96. 260–265. 16 indexed citations
11.
Rybicka, Magda & Krzysztof Piotr Bielawski. (2020). Recent Advances in Understanding, Diagnosing, and Treating Hepatitis B Virus Infection. Microorganisms. 8(9). 1416–1416. 23 indexed citations
12.
Rybicka, Magda, et al.. (2019). Host genetic background affects the course of infection and treatment response in patients with chronic hepatitis B. Journal of Clinical Virology. 120. 1–5. 5 indexed citations
13.
Rachoń, Dominik, et al.. (2018). Associations of ESR1 and ESR2 gene polymorphisms with metabolic syndrome and its components in postmenopausal women. Maturitas. 115. 97–102. 9 indexed citations
14.
Rybicka, Magda, et al.. (2017). Differences in sequences between HBV-relaxed circular DNA and covalently closed circular DNA. Emerging Microbes & Infections. 6(1). 1–7. 6 indexed citations
15.
Rybicka, Magda, Piotr Stalke, & Krzysztof Piotr Bielawski. (2016). Current molecular methods for the detection of hepatitis B virus quasispecies. Reviews in Medical Virology. 26(5). 369–381. 9 indexed citations
16.
Rybicka, Magda, Piotr Stalke, & Krzysztof Piotr Bielawski. (2014). Dynamics of hepatitis B virus quasispecies heterogeneity in association with nucleos(t)ide analogue treatment determined by MALDI-TOF MS. Clinical Microbiology and Infection. 21(3). 288.e1–288.e4. 6 indexed citations
17.
Rybicka, Magda, et al.. (2011). Wpływ polimorfizmu wirusa zapalenia wątroby typu B na przebieg choroby u osób przewlekle zakażonych. Postępy Higieny i Medycyny Doświadczalnej. 65. 244–254. 4 indexed citations
19.
Siński, E. & Magda Rybicka. (1980). Dynamics of basophils and mast cells and their in vitro degranulation in rats infected with Nippostrongylus brasiliensis.. Acta Parasitologica Polonica. 27. 541–549. 1 indexed citations
20.
Rybicka, Magda, et al.. (1980). Immunogenicity of methylcholanthrene-induced tumors tested by draining lymph node assay in syngeneic rats.. PubMed. 27(5). 533–42. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026